RevenueNet IncomeP/EP/SEBITDividendStocksMarket capitalizationDebtLiabilitiesEquityAAQSEmployeesROEROAROCE

Intellia Therapeutics ROE 2024

Intellia Therapeutics ROE

-0.46

Intellia Therapeutics Dividend yield

Ticker

NTLA

ISIN

US45826J1051

WKN

A2AG6H

In 2024, Intellia Therapeutics's return on equity (ROE) was -0.46, a 19.39% increase from the -0.38 ROE in the previous year.

Intellia Therapeutics Aktienanalyse

What does Intellia Therapeutics do?

Intellia Therapeutics Inc is a leading biotechnology company specializing in the development of therapeutic solutions based on CRISPR/Cas9 technologies. It was founded in May 2014 and is headquartered in Cambridge, Massachusetts, USA. The company is listed on NASDAQ under the ticker symbol NTLA. Intellia Therapeutics ist eines der beliebtesten Unternehmen auf Eulerpool.com.

ROE Details

Decoding Intellia Therapeutics's Return on Equity (ROE)

Intellia Therapeutics's Return on Equity (ROE) is a fundamental metric evaluating the company's profitability relative to its equity. Calculated by dividing net income by shareholder's equity, ROE illustrates how effectively the company is generating profits from shareholders’ investments. A higher ROE represents enhanced efficiency and profitability.

Year-to-Year Comparison

Analyzing Intellia Therapeutics's ROE on a yearly basis aids in tracking its profitability trends and financial performance. An increasing ROE suggests enhanced profitability and value generation for shareholders, whereas a declining ROE may indicate issues in profit generation or equity management.

Impact on Investments

Intellia Therapeutics's ROE is instrumental for investors assessing the company's profitability, efficiency, and investment attractiveness. A robust ROE indicates the firm’s adeptness at converting equity investments into profits, thereby enhancing its appeal to potential and current investors.

Interpreting ROE Fluctuations

Changes in Intellia Therapeutics’s ROE can emanate from variations in net income, equity capital, or both. These fluctuations are scrutinized to evaluate management’s effectiveness, financial strategies, and the inherent risks and opportunities, aiding investors in making informed decisions.

Frequently Asked Questions about Intellia Therapeutics Stock

What is the ROE (Return on Equity) of Intellia Therapeutics this year?

The ROE of Intellia Therapeutics this year is -0.46 undefined.

How has the Return on Equity (ROE) of Intellia Therapeutics developed compared to the previous year?

The ROE of Intellia Therapeutics has increased by 19.39% increased compared to the previous year.

What impact does a high ROE (Return on Equity) have on investors of Intellia Therapeutics?

A high ROE indicates that Intellia Therapeutics generates good returns on capital and is successful in monetizing its investments. This is a positive indicator for investors.

What impact does a low ROE (Return on Equity) have on investors of Intellia Therapeutics?

A low ROE can indicate that Intellia Therapeutics is having difficulties monetizing its investments successfully and can be a negative signal for investors.

How does a change in the ROE (Return on Equity) of Intellia Therapeutics affect the company?

A change in ROE (Return on Equity) of Intellia Therapeutics can be an indicator of the financial performance of the company and demonstrate how successful the company is compared to other companies in the same industry.

How to calculate the ROE (Return on Equity) of Intellia Therapeutics?

The ROE (Return on Equity) is calculated by dividing the company's profit by the total equity. The formula is: ROE = Profit / Total equity.

Which factors influence the ROE (Return on Equity) of Intellia Therapeutics?

Some factors that can influence Intellia Therapeutics's Return on Equity (ROE) include the efficiency in using equity, the profitability of the company, and the financing structure.

What strategic measures can take to improve the ROE (Return on Equity)?

To improve the Return on Equity (ROE), can take measures such as cost savings, increasing revenue, improving efficiency in the use of equity, and making changes in the financing structure. It is important for the company to conduct a thorough review of its financial situation to determine the best strategic actions to improve ROE.

How much dividend does Intellia Therapeutics pay?

Over the past 12 months, Intellia Therapeutics paid a dividend of . This corresponds to a dividend yield of about . For the coming 12 months, Intellia Therapeutics is expected to pay a dividend of 0 USD.

What is the dividend yield of Intellia Therapeutics?

The current dividend yield of Intellia Therapeutics is .

When does Intellia Therapeutics pay dividends?

Intellia Therapeutics pays a quarterly dividend. This is distributed in the months of .

How secure is the dividend of Intellia Therapeutics?

Intellia Therapeutics paid dividends every year for the past 0 years.

What is the dividend of Intellia Therapeutics?

For the upcoming 12 months, dividends amounting to 0 USD are expected. This corresponds to a dividend yield of 0 %.

In which sector is Intellia Therapeutics located?

Intellia Therapeutics is assigned to the 'Health' sector.

Wann musste ich die Aktien von Intellia Therapeutics kaufen, um die vorherige Dividende zu erhalten?

To receive the latest dividend of Intellia Therapeutics from 5/18/2024 amounting to 0 USD, you needed to have the stock in your portfolio before the ex-date on 5/18/2024.

When did Intellia Therapeutics pay the last dividend?

The last dividend was paid out on 5/18/2024.

What was the dividend of Intellia Therapeutics in the year 2023?

In the year 2023, Intellia Therapeutics distributed 0 USD as dividends.

In which currency does Intellia Therapeutics pay out the dividend?

The dividends of Intellia Therapeutics are distributed in USD.

Stock savings plans offer an attractive way for investors to build wealth over the long term. One of the main advantages is the so-called cost-average effect: by regularly investing a fixed amount in stocks or stock funds, you automatically buy more shares when prices are low, and fewer when they are high. This can lead to a more favorable average price per share over time. In addition, stock savings plans allow small investors access to expensive stocks, as they can participate with small amounts. Regular investment also promotes a disciplined investment strategy and helps to avoid emotional decisions, such as impulsive buying or selling. Furthermore, investors benefit from the potential appreciation of the stocks as well as from dividend distributions, which can be reinvested, enhancing the compounding effect and thus the growth of the invested capital.

Andere Kennzahlen von Intellia Therapeutics

Our stock analysis for Intellia Therapeutics Revenue stock includes important financial indicators such as revenue, profit, P/E ratio, P/S ratio, EBIT, as well as information on dividends. We also assess aspects such as stocks, market capitalization, debt, equity, and liabilities of Intellia Therapeutics Revenue. If you are looking for more detailed information on these topics, we offer comprehensive analyses on our subpages.